InsidersTradesSigma
Track the NAN stock price and the full management transaction log of the company, a publicly traded company based in Australia. Shares are quoted on the AU market, under the oversight of ASX. Operating in the Health Care sector, NAN has recorded 5 reports. Market capitalisation: €798.1m. The latest transaction was disclosed on 28 August 2026 (Purchase). Among the most active insiders: 2. Details of voting power. Every trade is openly available.
5
Insider Decl.
n/a
Thresholds
€17,652
1 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate NAN Buy (bullish), based on 8 analysts. Average price target: A$3.92.
Fundamental score
Ranked 13,445 of 28,985 companies
53.9
score / 100
Value37
Quality71
FCF yld2.1%
Earn yld2.2%
EV/EBITDA27.5x
ROE8.3%
Gross mgn77%
Net mgn8.7%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 August 2026
Declarations5 total
10,000 shares@ A$2.87ShareASXASX:2924-03128304-2A1693236
ShareASXASX:2924-03094961-2A1674400
ShareASXASX:2924-03089787-2A1671937
ShareASXASX:2924-03089364-2A1671731
ShareASXASX:2924-03088867-2A1671500
5 of 5 declarations
About NAN
NAN is a company operating in the healthcare and pharmaceutical sector, listed on the XASX. It focuses on developing innovative solutions to enhance patient health.
